Medicine & Life Sciences
Breast Neoplasms
100%
Trastuzumab
30%
Medical Oncology
18%
Drug Therapy
17%
Neoplasms
17%
Triple Negative Breast Neoplasms
15%
Therapeutics
14%
Recurrence
14%
Cancer Survivors
13%
Paclitaxel
13%
Adjuvant Chemotherapy
12%
Estrogen Receptors
12%
Guidelines
11%
Practice Guidelines
11%
Survivorship
10%
Hormones
10%
Survival
10%
Disease-Free Survival
9%
taxane
9%
Pathologists
8%
Breast
8%
Aromatase Inhibitors
8%
Capecitabine
7%
Anthracyclines
7%
Docetaxel
7%
Cyclophosphamide
7%
Biomarkers
7%
Clinical Trials
6%
Randomized Controlled Trials
6%
Doxorubicin
6%
Progesterone Receptors
5%
Ado-Trastuzumab Emtansine
5%
Systematic Reviews
5%
docosahexaenoyl-paclitaxel
5%